Zika Update

Possible case of locally acquired infection in Florida; experimental vaccine approved for US clinical trials

Written byTanya Lewis
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Aedes aegyptiCDC, JAMES GATHANYThe second reported case of Zika virus infection in Florida may have been acquired from mosquitoes in the U.S., health officials announced yesterday (July 22), STAT News reported. The patient lives in Broward County, which is close to Miami-Dade County, where the first Florida case was reported. If confirmed, the new case would be the first Zika infection spread by mosquitoes in the US.

“Today the Florida Department of Health announced that it is conducting an epidemiological investigation into a possible non-travel related case of Zika virus in Broward County,” the agency said in the statement.

The Florida Department of Health has not said whether the two cases may be linked, but has asked the US Centers for Disease Control and Prevention (CDC) to send a medical epidemiologist to help investigate. The department of health in Broward County will distribute Zika prevention kits and mosquito repellant, officials said.

On Monday, the Food and Drug Administration (FDA) approved the first US clinical trial of an experimental Zika vaccine, STAT reported. Inovio, of Plymouth Meeting, Pennsylvania, and GeneOne Life Science in Seoul, South Korea, will manufacture the vaccine. The trial will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies